PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.78%
Both yoy net incomes decline, with AVGO at -57.76%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.61%
Less D&A growth vs. AVGO's 50.72%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
117.39%
Some yoy growth while AVGO is negative at -256.61%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
45.24%
SBC growth well above AVGO's 46.69%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-174.23%
Negative yoy working capital usage while AVGO is 122.54%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-161.64%
AR is negative yoy while AVGO is 121.79%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
185.15%
Some inventory rise while AVGO is negative at -45.65%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-415.38%
Both negative yoy AP, with AVGO at -703.57%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-169.12%
Negative yoy usage while AVGO is 66.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
19.05%
Some yoy increase while AVGO is negative at -37.78%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-48.39%
Both yoy CFO lines are negative, with AVGO at -19.09%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.29%
CapEx growth well above AVGO's 6.60%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with AVGO at -94087.50%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
55.26%
Some yoy expansion while AVGO is negative at -100.00%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-26.77%
We reduce yoy sales while AVGO is 100.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
96.62%
We have some outflow growth while AVGO is negative at -700.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-22.06%
Both yoy lines negative, with AVGO at -12775.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-48.60%
Both yoy lines negative, with AVGO at -15649.57%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
297.37%
Stock issuance far above AVGO's 63.16%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
42.66%
We have some buyback growth while AVGO is negative at -129.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.